[HTML][HTML] The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
…, DR Bentley, IO Ellis, A Purushotham, SE Pinder… - Nature …, 2016 - nature.com
The genomic landscape of breast cancer is complex, and inter-and intra-tumour heterogeneity
are important challenges in treating the disease. In this study, we sequence 173 genes in …
are important challenges in treating the disease. In this study, we sequence 173 genes in …
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Germline mutations in BRCA1/2 predispose individuals to breast cancer (termed germline-mutated
BRCA1/2 breast cancer, gBRCA-BC) by impairing homologous recombination (HR) …
BRCA1/2 breast cancer, gBRCA-BC) by impairing homologous recombination (HR) …
Expression of luminal and basal cytokeratins in human breast carcinoma
DM Abd El‐Rehim, SE Pinder, CE Paish… - The Journal of …, 2004 - Wiley Online Library
We have examined basal and luminal cell cytokeratin expression in 1944 cases of invasive
breast carcinoma, using tissue microarray (TMA) technology, to determine the frequency of …
breast carcinoma, using tissue microarray (TMA) technology, to determine the frequency of …
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast …
Recent studies on gene molecular profiling using cDNA microarray in a relatively small
series of breast cancer have identified biologically distinct groups with apparent clinical and …
series of breast cancer have identified biologically distinct groups with apparent clinical and …
Terahertz pulsed spectroscopy of freshly excised human breast cancer
…, E Pickwell-MacPherson, E Provenzano, SE Pinder… - Optics express, 2009 - opg.optica.org
The complex refractive indices of freshly excised healthy breast tissue and breast cancers
collected from 20 patients were measured in the range of 0.15 - 2.0 THz using a portable …
collected from 20 patients were measured in the range of 0.15 - 2.0 THz using a portable …
[HTML][HTML] Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
Background Initial results of the UK/ANZ DCIS (UK, Australia, and New Zealand ductal
carcinoma in situ) trial suggested that radiotherapy reduced new breast events of ipsilateral …
carcinoma in situ) trial suggested that radiotherapy reduced new breast events of ipsilateral …
[HTML][HTML] An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
AE Teschendorff, A Miremadi, SE Pinder, IO Ellis… - Genome biology, 2007 - Springer
Background Estrogen receptor (ER)-negative breast cancer specimens are predominantly
of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and …
of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and …
[HTML][HTML] Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis
…, EA Rakha, CE Paish, AHS Lee, SE Pinder… - Modern Pathology, 2005 - Elsevier
Estrogen receptor (ER)-negative breast cancers are a group of tumors with poor prognosis
and fewer cancer prevention and treatment strategies compared to ER-positive tumors. The …
and fewer cancer prevention and treatment strategies compared to ER-positive tumors. The …
[HTML][HTML] High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
…, NL Barbosa-Morais, NP Thorne, JL Costa, SE Pinder… - Genome biology, 2007 - Springer
Background The characterization of copy number alteration patterns in breast cancer requires
high-resolution genome-wide profiling of a large panel of tumor specimens. To date, most …
high-resolution genome-wide profiling of a large panel of tumor specimens. To date, most …
[HTML][HTML] Addressing overtreatment of screen detected DCIS; the LORIS trial
…, L Billingham, D Dodwell, A Hanby, SE Pinder… - European journal of …, 2015 - Elsevier
Overdiagnosis, and thus overtreatment, are inevitable consequences of most screening
programmes; identification of ways of minimising the impact of overdiagnosis demands new …
programmes; identification of ways of minimising the impact of overdiagnosis demands new …